EP1210101A4 - Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers - Google Patents

Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers

Info

Publication number
EP1210101A4
EP1210101A4 EP00957363A EP00957363A EP1210101A4 EP 1210101 A4 EP1210101 A4 EP 1210101A4 EP 00957363 A EP00957363 A EP 00957363A EP 00957363 A EP00957363 A EP 00957363A EP 1210101 A4 EP1210101 A4 EP 1210101A4
Authority
EP
European Patent Office
Prior art keywords
elastic modulus
whole blood
blood clot
contractile force
clinical markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00957363A
Other languages
German (de)
French (fr)
Other versions
EP1210101A1 (en
Inventor
Marcus E Carr Jr
Ashok Dr Krishnaswami
Erica J Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemodyne Inc
Original Assignee
Hemodyne Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemodyne Inc filed Critical Hemodyne Inc
Publication of EP1210101A1 publication Critical patent/EP1210101A1/en
Publication of EP1210101A4 publication Critical patent/EP1210101A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00957363A 1999-08-13 2000-08-11 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers Withdrawn EP1210101A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14859599P 1999-08-13 1999-08-13
US148595P 1999-08-13
PCT/US2000/021848 WO2001012211A1 (en) 1999-08-13 2000-08-11 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers

Publications (2)

Publication Number Publication Date
EP1210101A1 EP1210101A1 (en) 2002-06-05
EP1210101A4 true EP1210101A4 (en) 2005-10-12

Family

ID=22526455

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00957363A Withdrawn EP1210101A4 (en) 1999-08-13 2000-08-11 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers

Country Status (7)

Country Link
EP (1) EP1210101A4 (en)
JP (1) JP2003507693A (en)
KR (1) KR20020043556A (en)
CN (1) CN1370075A (en)
AU (1) AU778160B2 (en)
CA (1) CA2380972A1 (en)
WO (1) WO2001012211A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573104B2 (en) * 2001-05-10 2003-06-03 Hemodyne, Incorporated Disposable cup and cone used in blood analysis instrumentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5293772A (en) * 1992-01-17 1994-03-15 Center For Innovative Technology Instrumentation and method for evaluating platelet performance during clotting and dissolution of blood clots and for evaluating erythrocyte flexibility
US5205159A (en) * 1992-01-17 1993-04-27 Virginia Commonwealth University Apparatus and method for measuring clot elastic modulus and force development on the same blood sample
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0112211A1 *

Also Published As

Publication number Publication date
CA2380972A1 (en) 2001-02-22
AU6899500A (en) 2001-03-13
AU778160B2 (en) 2004-11-18
WO2001012211A1 (en) 2001-02-22
CN1370075A (en) 2002-09-18
KR20020043556A (en) 2002-06-10
JP2003507693A (en) 2003-02-25
EP1210101A1 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
AU2002256086A1 (en) Methods of isolating blood components using a centrifuge and uses thereof
AU2001249389A1 (en) Modified blood clotting factors and methods of use
EP1539275A4 (en) Blood aspiration system and methods of use
AU2001275047A1 (en) Method of graphically indicating patient information
EP1141699A4 (en) Devices and methods for performing blood coagulation assays by piezoelectric sensing
AU4422800A (en) Method of analysis of medical signals
GB0131024D0 (en) Analysis of acoustic medical signals
HK1038874A1 (en) Method of making prefastened disposable absorbent articles
DE50014699D1 (en) Medical instrument for the preparation of tissue
PT1237827E (en) PREPARATION OF BETAO ACCELERATOR
ID25792A (en) ANTIBODIES OF HUMAN CD40
AU2585799A (en) Non-invasive optical measurement of blood hematocrit
AU2002227400A1 (en) Sensor for transcutaneous measurement of vascular access blood flow
PT1150966E (en) METHOD OF PREPARATION OF 5-CYANOFOHALIDE
HUP0001699A2 (en) Arrangement for decanting of blood
HK1066861A1 (en) Method of measuring whole blood
AU2002356509A8 (en) Diagnosis of flavivirus infection
EP1210101A4 (en) Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers
GB2356058B (en) Bond durability test of sfrc
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
GB9922482D0 (en) Method of diagnosis
HU0101713D0 (en) Process for the preparation of artificial blood
AU2001239523A1 (en) Blood transfusion method and device
GB0103495D0 (en) Methods of preparing organmetallic compounds and novel organmetallic dimers
IL145130A0 (en) Method for localization of blood clots

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020311

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MARTIN,ERICA J.

Inventor name: KRISHNASWAMI,ASHOK,DR.

Inventor name: CARR, MARCUS, E., JR.

A4 Supplementary search report drawn up and despatched

Effective date: 20050825

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/56 B

Ipc: 7G 01N 33/86 B

Ipc: 7A 61K 38/48 B

Ipc: 7A 61K 38/00 A

Ipc: 7C 12Q 1/68 B

Ipc: 7G 01N 33/49 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301